For parents and caregivers, the ability to distinguish between RSV, Flu, and COVID can be critical to determine what treatment path to follow. The Flowflex Plus 4-in-1 test is the first respiratory ...

FDA-cleared test enables at-home detection of RSV, Flu A/B and COVID in adults and pediatric populations. SAN DIEGO, Jan. 23, 2026 /PRNewswire/ -- ACON Laboratories, Inc. today announced the retail ...

ACON Laboratories, Inc. announced the retail availability of the first FDA-cleared home test which allows families to identify four major respiratory infections, including respiratory syncytial virus ...

CLEVELAND, Ohio — Families can now test for flu, COVID-19 and respiratory syncytial virus with one at-home test. The Flowflex® Plus RSV + Flu A/B + COVID 4-in-1 test is now available in Northeast Ohio ...

The availability of a four-in-one respiratory virus diagnostic for home use may be a boon to consumers, but some clinicians say it should not be used as a substitute for a physician’s guidance.

Acon Laboratories, founded by Jixun Lin, makes the Flowflex at-home COVID-19 tests that took off during the pandemic after receiving U.S. FDA authorization for emergency use in 2021 and clearance for ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

By ACON Laboratories, Inc. Jan 23, 2026 Jan 23, 2026 0 1 of 2 ACON Labs LOGO Hand-out Flowflex® LOGO Hand-out By ACON Laboratories, Inc.